Cohort B (n=662) | Cohort H (n=629) | P value | |
Access site, n (%) | |||
Femoral | 131 (19.8%) | 79 (12.6%) | <0.01 |
Culprit lesion, n (%) | 0.60 | ||
LMS | 16 (2.2%) | 24 (3.4%) | 0.18 |
LAD | 270 (37.8%) | 272 (38.9%) | 0.91 |
LCx | 127 (17.8%) | 126 (18.0%) | 0.92 |
RCA | 289 (40.5%) | 264 (37.7%) | 0.29 |
Graft | 12 (1.7%) | 14 (2.0%) | 0.66 |
Number of bystander lesions (n %)* | 390 (35.3%) | 308 (30.6%) | 0.02 |
Number of lesions attempted (n %)* | 822 (74.5%) | 834 (82.7%) | <0.01 |
Number of stents per patient, mean (SD) | 1.3±0.8 | 1.4±0.9 | 0.01 |
Drug eluting stent, (n %)† | 815 (95.5%) | 866 (97.6%) | 0.02 |
Stent diameter, mean (SD) | 3.3±0.7 | 3.4±1.5 | 0.11 |
Stent length, mean (SD) | 27.1±10.2 | 27.8±11.2 | 0.09 |
TIMI flow in the culprit artery at the end of the procedure, n (%)‡: | 0.17 | ||
0–1 | 20 (2.8%) | 12 (1.7%) | |
2–3 | 694 (97.2%) | 688 (98.3%) | |
Number of lesions successful, n (%)§: | 793 (96.5%) | 799 (95.8%) | 0.48 |
Use of a thrombus extraction catheter, n (%): | 297 (44.9%) | 78 (12.4%) | <0.01 |
Use of a vascular closure device system, n (%)¶: | 107 (81.7%) | 76 (96.2%) | <0.01 |
Thrombotic procedural complications, n (%): | 21 (3.17%) | 13 (2.07%) | 0.22 |
If more than one stent is used, the stent length denotes the sum of all stent lengths.
LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; LMS, left main stem; RCA,right coronary artery.